bat6021
mAbexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Oct 29, 2021 (NCT05073484)
Timeline
2020s
- Jan 1, 2021
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05120375 | Phase 1 | Nov 30, 2021 | Biothera, Shantou University |
| NCT05073484 | Phase 1 | Oct 29, 2021 | Biothera, University of Liverpool |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Biothera | For profit | 2 | 2 | 1 | 2021 |
| Shantou University | Academic/Hospital | 1 | 0 | 1 | 2021 |
| University of Liverpool | Academic/Hospital | 1 | 0 | 1 | 2021 |
3 organizations
Page 1 / 1